Vancomycin Prophylaxis
Vancomycin Prophylaxis is a surgical prophylaxis method in which vancomycin, a glycopeptide antibiotic, is administered preoperatively to prevent surgical site infections caused by resistant gram-positive pathogens, particularly in patients at high risk for methicillin-resistant Staphylococcus aureus (MRSA) colonization or in settings with high MRSA prevalence.
323
Publications
17.1K
Citations
1.6K
Authors
538
Institutions
Publications per year
2017–2026
79
323
1–5 of 323
1.6K
5
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 1.6K
538

Brigham and Women's Hospital
Boston, United States
10 h-index
32 publications
1.2K citations
Harvard University
Cambridge, United States
8 h-index
29 publications
1.2K citations

University of Liverpool
Liverpool, United Kingdom
7 h-index
24 publications
1.2K citations
Vanderbilt University Medical Center
Nashville, United States
6 h-index
22 publications
2.3K citations
University of California, Los Angeles
Los Angeles, United States
5 h-index
28 publications
1.1K citations
University of Illinois Chicago
Chicago, United States
5 h-index
15 publications
270 citations
The University of Texas Southwestern Medical Center
Dallas, United States
5 h-index
7 publications
243 citations
Emory University
Atlanta, United States
5 h-index
15 publications
650 citations
1–8 of 538
AAC · 18 publications · 810 citations
16
h-index
Repository · 18 publications · 610 citations
15
h-index
CID · 12 publications · 1.1K citations
12
h-index
ICHE · 11 publications · 629 citations
10
h-index
10 publications · 1.4K citations
10
h-index
1–5